Liddle's syndrome is a form of inherited hypertension linked to mutations in the genes encoding the epithelial Na ؉ channel (ENaC 
The amiloride-sensitive epithelial Na ϩ channel (ENaC) plays an important role in the regulation of Na ϩ homeostasis and therefore control of blood volume and blood pressure. It is located at the apical membrane of principal cells of the cortical collecting duct, but is also expressed in the distal colon, in the lung, and in the ducts of exocrine glands (salivary, mammary, sweat glands) (1) . ENaC, which facilitates the entry of Na ϩ from the lumen into the cells, is composed of three homologous subunits (␣␤␥) (2, 3) that contain two transmembrane domains, a large extracellular loop and short intracellular amino and carboxyl termini (4 -6) . All three subunits have conserved proline-rich regions conforming to the consensus of PY motifs (xPPxY; Pϭproline, Yϭtyrosine, xϭany amino acid) in their carboxyl-terminal tail (7) . In the cortical collecting duct, ENaC is under tight hormonal control, namely, by aldosterone and vasopressin, but the molecular mechanisms of this regulation are not known. A functional ENaC channel is essential as evidenced by the genetic linkage with two diseases affecting blood pressure: pseudohypoaldosteronism type I (8, 9 ) and Liddle's syndrome (10) . The latter is an autosomal, dominant form of human hypertension (11) characterized by early onset of severe hypertension, hypokalemia, metabolic alkalosis, and low plasma levels of renin and aldosterone. The disease is caused by mutations in the genes encoding either ␤-(12) or ␥ENaC (13) . To date, all identified mutations are located in the regions encoding the carboxyl termini of these subunits and they invariably delete or modify the PY motifs (14 -17) , known to interact with WW domains (protein-protein interaction modules). Using the twohybrid technique, we have identified the rat ubiquitinprotein ligase Nedd4 (rNedd4) as a binding partner of the rat ENaC (rENaC) PY motifs (18) . rNedd4, which is composed of one C2 (calcium-dependent lipid binding) domain, three WW domains, and a HECT (ubiquitin-protein ligase) domain, binds rENaC via its WW domains. The identification of a ubiquitin-protein ligase as an interacting partner of ENaC pointed at ubiquitination (the modification of target proteins with ubiquitin moieties) as a possible mechanism of ENaC regulation. Consistent with the well-established function of ubiquitination as a signal for the rapid internalization/degradation of membrane proteins (reviewed in refs 19 -21) , we demonstrated that rENaC is a protein with a short half-life (T 1/2 ϳ 1 h) that is regulated by ubiquitination (22) . Moreover, we and others have provided evidence that Nedd4 is able to regulate ENaC activity when coexpressed in oocytes by controlling the number of channels at the cell surface (23) (24) (25) . A relationship between an epithelial Na ϩ 1 Correspondence: Institute of Pharmacology and Toxicology, University of Lausanne, Rue du Bugnon 27, CH-1005 Lausanne, Switzerland. E-mail: olivier.staub@ipharm.unil.ch channel and Nedd4 was also demonstrated in salivary duct cells, although the nature of the observed channel is unclear (26) . However, though we found that in Xenopus oocytes Xenopus Nedd4 (xNedd4) does regulate rENaC, we were not able to show rENaC regulation and in vivo binding by rat Nedd4 (rNedd4). This prompted us to look for other mammalian, physiologically more relevant Nedd4 proteins.
MATERIALS AND METHODS
Cloning of mNedd4 isoforms from mpkCCD c14 cell line and cDNA constructs used Mouse Nedd4 -1 (mNedd4 -1) was amplified by reverse transcriptase-polymerase chain reaction (RT-PCR) using random primer (Pharmacia, Piscataway, N.J.) for reverse transcription of mpkCCD c14 cell (27) total RNA and primers 5Ј-CCAGAT-GCTGCCACTCATTTGCCGC-3Ј (sense, nt 916 -940 GenBank no. D85414) and 5Ј-GCCTAAGACTCACTACA-CACTG-3Ј (antisense, nt 3509 -3530) for PCR. For the 5Ј-end we performed 5Ј-RACE-PCR (28), reverse transcribing total RNA from mpkCCD c14 with random primers, and PCR with nested primers 5Ј-ATCTCTGGAGTAGGGCACTGCTGGT-3Ј (antisense, nt 1734 -1710) and 5Ј-CAGCCTGACCAC-TATACTCGG-3Ј (antisense, nt 1228 -1208). Several cDNAs were cloned and sequenced and found to correspond to the sequence reported by Kumar et al. (GenBank accession no. D85414). One 5Ј-RACE clone was cloned into pGEMT vector (Promega, Madison, Wis.), sequenced, found to range from nucleotide 169 to 1230 (GenBank accession no. D85414), and used for subsequent reconstitution of a full-length mNedd4 -1 cDNA. This was achieved by ligating an EcoRI/ XbaI 5Ј fragment (nt 169-1024) and a XbaI/EcoRI 3Ј fragment (nt 1025-3530) into the pSDeasy plasmid (29) . A catalytically inactive mNedd4 -1 mutant was generated by mutating the essential cysteine 850 to serine using PCR (30) . A full-length clone encoding mouse Nedd4 -2 was obtained as follows: Based on the sequence information present in several expressed sequence tags (ESTs) (AI527754, AI315046, AA118878), we amplified from mpkCCD c14 total RNA 3 overlapping PCR fragments by RT-PCR using the following primers: 1) 5Ј-GCTGTTGTTAAGGAAAACAGACC-3Ј (nt 1-23) and 5Ј-TCCATGGTTGGATCTTCTGTCGG-3Ј (319 -341; antisense); 2) 5Ј-CCGACAGAAGATCCAACCATGGA-3Ј (319 -341; sense) and 5Ј-GCTCTATTGTAAACAGCTGAG-GACC-3Ј (2737-2761); and 3) 5Ј-AGCTCATACATGCTTTA-ATCGCCTT-3Ј (2790 -2814) and 5Ј-AAGCAGTGGTAA-CAACGCAGAGTTTTTTTTT-3Ј. The fragments were first subcloned into pGEMT plasmid and sequenced, then assembled by triple ligation of fragments EcoRI/NcoI (nt 1-335), NcoI/SalI (nt 335-2548) and SalI/NotI (nt 2548 -3325) into the pSDeasy plasmid linearized by EcoRI and NotI. A catalytically inactive mutant mNedd4 -2, generated by mutating cysteine 822 to serine by PCR (30) and an amino-terminally truncated mutant (mNedd4 -2-⌬N; amino acids 1 to 288 deleted) were cloned into the pSDeasy plasmid. The following residues in the WW domains of Xenopus Nedd4 (31) were mutated by PCR: WW domain 1: tryptophan 218 to phenylalanine and proline 221 to alanine; WW domain 2: tryptophan 409 to phenylalanine and proline 412 to alanine; WW domain 3: tryptophan 521 to alanine and proline 524 to alanine; WW domain 4: tryptophan 572 to 575; the mutants were cloned into pSDeasy. The rENaC constructs have been described previously by Schild et al. (32) and the constructs containing a FLAG epitope by Firsov et al. (33) .
Expression and function of rENaC channels in Xenopus oocytes
For functional expression studies, rENaC and mNedd4 constructs were transcribed using SP6-RNA polymerase and 10 ng cRNA encoding rENaC (3.3 ng of each subunit) with or without 25 ng cRNA encoding mNedd4 -1, mNedd4 -2, or xNedd4 were coinjected into Xenopus oocytes (as described previously ref 23) . Electrophysiological measurements were performed 12 to 24 h after cRNA injection using the twoelectrode voltage-clamp technique, as described before (32) , by measuring the current sensitive to 10 M amiloride in a 120 mM Na ϩ frog Ringer solution at a holding potential of Ϫ100 mV. All values were normalized to the control value (oocytes only injected with rENaC) in one given batch of oocytes. Data are presented as mean Ϯ se. The statistical significance of the differences between the means was estimated using bilateral Student's t test for unpaired data.
Culture of mpkCCD c14 cells
Cells were grown in a hormonally defined DMEM:Ham's F12 (1:1) medium supplemented with 2% of fetal calf serum in an atmosphere of humidified air/5% CO 2 at 37°C on collagencoated Transwell permeable filters (Costar, Cambridge, Mass.) as described by Bens et al. (27) .
Biochemical analyses
After the electrophysiological measurements, oocytes were kept at 4°C, pooled, and lysed in (20 l/oocyte) Triton X-100 homogenization buffer (20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 1% Triton X-100, 1 mM PMSF, 10 g/ml leupeptin, 10 g/ml peptstatin A, 10 g/ml aprotinin) at 4°C. After centrifugation at 4°C for 10 min at 14,000 rpm, the supernatant was recovered and stored at Ϫ80°C. Lysate from mpkC-CD c14 cells growing on filter were prepared using lysis buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EGTA, 1% Triton X-100, 10% glycerol, 1 mM PMSF, 10 g/ml leupeptin, 10 g/ml pepstatin A, 10 g/ml aprotinin); insoluble material was removed by centrifugation. For the coimmunoprecipitations, oocytes coinjected with cRNA encoding rENaC (with or without a FLAG epitope on the extracellular loop; ref 33) and mNedd4 -1 or mNedd4 -2 were incubated overnight in 0.1 mCi/ml [ 35 S]methionine and homogenized in 50 mM HEPES, pH 7.4, 83 mM NaCl, 1 mM MgCl 2 , 1 mM PMSF, 10 g/ml leupeptin, 10 g/ml pepstatin A, 10 g/ml aprotinin. An aliquot was removed for analysis of the total homogenate. Membranes were prepared by centrifugation at 4°C for 10 min at 3000 rpm in a microfuge, followed by centrifugation of the supernatant at 4°C for 20 min at 14,000 rpm. The recovered membranes were solubilized in 50 l/oocyte of lysis buffer. Coimmunoprecipitations were performed with anti-FLAG antibody (Kodak) and protein G Sepharose (Sigma). The homogenate and the immunoprecipitated material was then analyzed either by Western blotting or by autoradiography. For Western blot analysis, material was separated either on 5-13% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gradient gel or on 7% SDS-PAGE minigels, transferred onto nitrocellulose, and then immunoblotted as described before, using an anti-rNedd4-WW2 antibody at a dilution of 1:1000 (18) . Two-dimensional (2D) gel electrophoresis using the mini-gel system of Bio-Rad Laboratories was carried out as described (34) .
Northern blot analysis
A multiple tissue Northern blot (MTN) containing ϳ2 g of purified poly(A) ϩ RNA per lane from eight different mouse tissues was obtained from Clontech (Palo Alto, Calif.). The blot was prehybridized for 1 h at 65°C in ExpressHyb (Clontech) according to the directions of the manufacturer. A NdeI/XhoI fragment (nt 2830 -3330) situated at the 3Ј noncoding portion of mNedd4 -2 cDNA, a mNedd4 -1 HindIII/ HindIII fragment (nt 1807-3497), or ␤-actin cDNA (provided by Clontech) was used as a random primed 32 P-labeled probe. Hybridization was for 1 h at 65°C. The blot was washed quickly four times with 2ϫ SSC, 0.05% SDS, three times for 10 min at room temperature with 2ϫ SSC, 0.05% SDS, and twice for 20 min at 65°C with 0.1ϫ SSC and autoradiography was performed.
RESULTS

Cloning of a novel mouse Nedd4 isoform
We have recently shown that Xenopus laevis Nedd4 (xNedd4, cloned from Xenopus kidney derived A6 cells; 31) acts as a negative regulator of the rat epithelial Na ϩ channel (rENaC) when coexpressed in Xenopus oocytes (23) . Both xNedd4 and human Nedd4 (hNedd4) contain four WW domains (31), but there are only three in mouse (mNedd4) or rat Nedd4 (rNedd4) (18, 35) . Moreover, there is another human protein with homology to xNedd4 (KIAA0439; GenBank accession no. AB007899). To determine whether several Nedd4 isoforms exist, we performed a BLAST search (36) in the mouse EST GenBank database for mouse homologues of Nedd4. Indeed, we found two populations of mNedd4 EST sequences, one being identical to the original mNedd4 (37) and the other one homologous to xNedd4 (31) and human KIAA0439. This finding suggested the existence of a novel Nedd4 isoform in mice. Based on the sequence information available from the mouse ESTs, we cloned the two mNedd4 isoforms from cultured mouse mpkCCD c14 cells. These cells are derived from the cortical collecting duct (CCD), a model epithelium for the study of amiloridesensitive Na ϩ transport (27) . The first isoform is identical to the Nedd4 protein identified by Kumar and collaborators (35, 37) (accession no. D85414), which we propose to name mNedd4 -1. It contains one C2, three WW, and one HECT domain and is homologous to rNedd4 (rNedd4 -1) and the human KIAA0093 gene product (hNedd4 -1; Fig. 1 ). In contrast, the other mNedd4 isoform, referred to here as mNedd4 -2, is with 89% similarity to the hypothetical gene product of human KIAA0439 gene (which we propose to name hNedd4 -2) and 86% to xNedd4 yet clearly different from Nedd4 -1 (52 to 58% similarity, depending on the species). The sequence of the cloned mNedd4 -2 cDNA (3325 base pairs) predicts an open reading frame of 855 amino acids, starting at position 337 (GenBank accession no. AF277232) and containing a translation initiation site, which fits the Kozak consensus sequence well (38) . Analyzing the deduced protein sequence with the SMART tool program (39) , four WW and one HECT domain are predicted. Three of these WW domains (1, 2, and 4) are highly conserved among Nedd4 isoforms (Fig. 1) . In contrast, the third, additional WW domain is identical to the ones in hNedd4 -2 and xNedd4 and partially similar to the inserted WW domain in hNedd4 -1 (Fig. 1) .The predicted protein of mNedd4 -2 does not contain the amino-terminal C2 domain, as we consistently found in several clones originating from different sources (mpkCCD c14 or total mouse kidney) a stop codon upstream of the initiating methionine. This stop codon is also present in all EST sequences covering this region, three of which we have confirmed by sequencing.
Northern blot analysis on a multiple tissue blot, using a 3Ј-noncoding region cDNA probe, reveals that a 3.8 kb mNedd4 -2 mRNA is highly expressed in liver and kidney, to a lesser extent in heart, brain, and lung and is barely detectable in spleen, skeletal muscle, and testis (Fig. 2, top panel) . The size and tissue distribution of mNedd4 -2 mRNA are different from mNedd4 -1, which is ubiquitously expressed and has a size of ϳ6.0 kb (middle panel; see also ref 35) . From the estimated size of the mNedd4 -2 mRNA we cannot exclude the possibility that our cDNA clones are not full length. Indeed, there are at least two EST sequences in GenBank that contain additional 5Ј-sequences, but attempts to clone these regions failed.
mpkCCD c14 cells express both the mNedd4 -1 and mNedd4 -2 protein
To detect mNedd4 -1 and mNedd4 -2 in mpkCCD c14 cells, we performed immunoblot analysis on mpk-CCD c14 lysates using an antibody directed against the WW domain 2 of rNedd4 -1 (18) (Fig. 3A, lane 4) . The antibody recognized two proteins with apparent molecular masses of 115 kDa and 105 kDa, respectively. As shown on the same blot, the 115 kDa band migrates at the same size as mNedd4 -1 when expressed in oocytes (Fig. 3A, compare lanes 1 and 4) and the 105 kDa band is equal in size to mNedd4 -2 (lanes 2 or 3 and 4). In addition, both proteins are recognized by three additional anti Nedd4 antibodies (anti-rNedd4-HECT, antirNedd4-Nt, and anti xNedd4; data not shown). To further corroborate that these bands represent mNedd4 -1 and mNedd4 -2, we analyzed a mpkCCD c14 cell lysate by 2D gel electrophoresis and Western blotting (Fig. 3B ). mNedd4 -1 has a calculated molecular mass of 103 kDa and a pI of 5.12, as compared to mNedd4 -2 with 97 kDa and a pI of 5.8. Several spots are seen at an apparent molecular mass of ϳ115 kDa that correspond to the size of Nedd4 -1 and migrate in a pH range between 5 and 5.2. These spots probably represent differentially phosphorylated forms of mNedd4 -1, as we have found that mNedd4 -1 is a phosphoprotein (E. Kamynina and O. Staub, unpublished results). At ϳ105 kDa we observe a protein that migrates at a more basic pH of ϳ5.8, the predicted pI of mNedd4 -2. The same spots are also recognized by an antibody directed against rNedd4 -1 HECT (data not shown). Hence, both mNedd4 -1 and mNedd4 -2 proteins are expressed in mpkCCD c14 cells.
mNedd4 -2, but not mNedd4 -1, regulates rENaC in Xenopus oocytes
To determine whether mNedd4 -2 has the potential to regulate rENaC, we expressed either wild-type mNedd4 -2 or a catalytically inactive mutant in Xenopus oocytes. In the mutant, the cysteine 822 in the HECT domain was replaced by serine (mNedd4 -2 CS). The correct expression of the wild-type and mutant Nedd4 was confirmed by Western blot analysis (Fig. 3A) . We then measured amiloride-sensitive Na ϩ currents in these oocytes (Fig. 4) . We found that wild-type mNedd4 -2 was able to abrogate rENaC activity when compared to control oocytes (rENaC/H 2 O) whereas the inactive mNedd4 -2 mutant increased this activity by more than twofold, likely by competing against endogenous xNedd4 (23) . An aminoterminally truncated mNedd4 -2 protein (mNedd4 -2-⌬N) was also able to down-regulate rENaC (see below). On the other hand, when wild-type mNedd4 -1 was coexpressed with rENaC, channel activity was not altered (Fig.  4A , rENaC/mNedd4 -1), whereas the corresponding CS mutant had a minor stimulatory effect (rENaC/ mNedd4 -1 CS). Both mNedd4 -1 proteins were correctly expressed (not shown). Similar data were obtained with rNedd4 -1 or hNedd4 -1 (E. Kamynina and O. Staub, unpublished results), reinforcing the finding that Nedd4 -1 is not primarily involved in rENaC regulation.
mNedd4 -1 does not bind to rENaC when coexpressed in Xenopus oocytes
To understand why Nedd4 -1 does not regulate rENaC, we investigated whether differences in rENaC binding between the two isoforms exist. We performed coimmunoprecipitation experiments, by coexpressing rENaC, that either contained (Fig. 5A, lanes 4 -6) or not (lanes 1-3) a FLAG epitope within its extracellular loop (33), with mNedd4 -1 or mNedd4 -2. Oocytes were metabolically labeled, a membrane fraction was solubilized and immunoprecipitated with an anti-FLAG antibody. The precipitated proteins were then analyzed by SDS-PAGE and autoradiography and/or Western blotting. All three rENaC subunits were precipitated when the FLAG epitope was present (Fig. 5A, top panel,  lanes 4 -6) . Moreover, when mNedd4 -2 was coexpressed, an additional band at ϳ105 kDa was seen (top panel, lane 6), which we identified as mNedd4 -2 by Western blotting using an anti-Nedd4 antibody (middle panel, lane 6). No protein coimmunoprecipitated when mNedd4 -1 cRNA was injected (top and middle panel, lane 5), despite equal expression levels with mNedd4 -2 (bottom panel, compare lanes 5 and 6). This suggests that the slight stimulatory effect of the mNedd4 -1 CS mutant on ENaC activity, as observed in Fig. 4 , is indirect, likely by affecting cellular mechanisms such as endocytosis. We conclude that mNedd4 -1 does not have the potential to directly regulate rENaC, because it does not bind to the channel complex when coexpressed in oocytes. When we performed the same experiment with either wild-type or mutant Nedd4 -2, we did not observe a difference in either the quantity of the total pool of rENaC subunits or the amount of Nedd4 -2 bound to rENaC (Fig. 5B) . Because rENaC cell surface expression is down-regulated by xNedd4 (the Xenopus homologue of mNedd4 -2) (23), it is likely that the primary interac- ϩ RNA from the indicated tissues was hybridized either with a probe derived from mNedd4 -2 (top), mNedd4 -1 (middle), or ␤-actin (bottom) as described in Materials and Methods. tion between Nedd4 -2 and rENaC observed in these experiments occurs at intracellular locations.
Each rENaC PY-motif is involved in Nedd4 -2 binding
We wanted to determine how the different PY motifs on the three rENaC subunits contribute to the binding to Nedd4 -2. We therefore systematically mutated the tyrosine residues in each PY motif, mutations expected to abolish the interaction with WW domains, and analyzed the effect of Nedd4 -2 (wild-type or CS mutant) on these mutant channels (Fig. 6) . As previously reported (32), the sequential removal of PY motifs leads to an increase of ENaC activity (Fig. 6A, columns  1-8) , as revealed by a comparison of wild-type channels (white column 1) to channels with one PY motifs deleted (gray, columns 2-4), two PY motifs deleted (striped, columns 5-7), or three PY motifs deleted (black, column 8). When wild-type mNedd4 -2 is coexpressed (columns 9 -16), the negative effect of mNedd4 -2 is progressively lost as the number of mutated PY motifs increases (compare white column 9 to gray columns 10 -12, striped columns 13-15 or black column 16). Consistently, the same PY motif-dependent pattern can be seen with the mNedd4 -2 CS mutant (columns [17] [18] [19] [20] [21] [22] [23] [24] . We also note that the presence of a single PY motif is sufficient to yield an effect on rENaC currents (Fig. 6A , compare striped columns 5-7 to 13-15 or 21-23) and interaction with Nedd4 -2 (Fig.  6B, lanes 3-5) . It also appears that the PY motif on ␤ rENaC is more important for rENaC function than those on ␣ and ␥ (Fig. 6A , compare gray columns in each condition to each other or the striped columns in each condition). When all the PY motifs are deleted, there is not more interaction with mNedd4 -2 (Fig. 6B , lane 2) and no significant difference between the control condition H 2 O/␣ Y673A ␤ Y618H ␥ 628A (Fig. 6A , column 8) and mNedd4 -2/␣ Y673A ␤ Y618H ␥ 628A (Fig. 6A,  column 16 ) or between control and mNedd4 -2-CS/ ␣ Y673A ␤ Y618H ␥ 628A (Fig. 6A, compare columns 8 and  24) . Thus, these data (Fig. 6) demonstrate that there is an absolute requirement for at least one PY motif on rENaC in order to observe an effect of Nedd4 -2 on rENaC regulation. We note that patients with Liddle's syndrome, possessing a mutation in a single PY motif, are clearly affected. It is therefore possible that through overexpression we may reach the limits of the oocyte system.
The WW domains 3 and 4 mediate binding to rENaC
Having established that all PY motifs are involved in rENaC/Nedd4 -2 interaction we asked which WW domains play a role in rENaC binding. Such experiments were done with the Xenopus homologue (xNedd4) of mNedd4 -2, which is highly homologous and contains nearly identical WW domains. We individually mutated each WW domain of xNedd4, the second conserved tryptophan to phenylalanine and the conserved proline into alanine. These mutations are expected to abolish binding to PY motifs (40, 41) . These mutant xNedd4 proteins were then coexpressed in Xenopus oocytes and their effect on rENaC activity was analyzed (Fig. 7A) . We found that mutation of the first WW domain in xNedd4 did not effect xNedd4-dependent rENaC regulation, whereas mutation of the second WW domain had a minor effect and changing the third or fourth WW domain had more significant consequences for the xNedd4/rENaC interaction (Fig. 7A) . We then made double mutants in which we mutated the first and second WW domains together or, alternatively, the third and fourth together (Fig. 7B) . We expressed these constructs in a dose-dependent manner and observed that mutation of the first two WW domains did not impair the capability of Nedd4 -2 to down-regulate rENaC. On the other hand, mutation of the third or fourth WW domain completely abolished the potency of Nedd4 -2 to control rENaC activity, suggesting that WW domains 3 and 4 are principally involved in rENaC binding. This was further validated with a truncated form of mouse Nedd4 -2, which had the first two WW domains deleted (Fig. 4, rENaC/mNedd4 -2⌬N) ; this mutant was as effective as wild-type mNedd4 -2 in regulating rENaC, corroborating the observation that Figure 6 . All the PY motifs are involved in rENaC/Nedd4 -2 interaction. A) Oocytes were injected with either wild-type or mutated rENaC alone (as indicated) (columns 1-8) or together with mNedd4 -2 (columns 9 -16) or mutated mNedd4 -2 (CS mutant, columns [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] , and the amiloride-sensitive Na ϩ current was measured. The measured currents are normalized to 1 for control currents (column 1). n ϭ 14 oocytes from two different frogs. N.S. ϭ not significant. B) Oocytes were injected with cRNA encoding mNedd4 -2 and either wild-type or mutant flagged rENaC subunits (as indicated). Oocytes were labeled overnight with [ 35 S]methionine and homogenized; a membrane fraction was solubilized and immunoprecipitations were performed with anti-FLAG antibodies. The precipitated material was analyzed by SDS-PAGE/autoradiography (top panel) or SDS-PAGE and Western blotting with an anti Nedd4 antibody (middle panel). An aliquot of the homogenate was also analyzed by Western blotting (bottom panel) to control for proper Nedd4 -2 expression.
essentially the third and fourth WW domains are important for rENaC binding.
DISCUSSION
The major finding of this study is that at least two mouse Nedd4 isoforms (mNedd4 -1 and mNedd4 -2) exist and that only one of them-mNedd4 -2, but not mNedd4 -1-has the capability to bind to and control the activity of rENaC. The two isoforms, which in mouse share 52% identity or 62% similarity, show a slightly different molecular organization. Whereas mNedd4 -1, the original Nedd4 protein described (35, 37) , contains one C2, three WW, and one HECT domain, mNedd4 -2 has no C2, but has four WW and one HECT domain. Both isoforms have homologues in humans and rats. In Xenopus laevis, only a Nedd4 -2 homologue has been identified (see Fig. 1 ).
Intriguingly, mNedd4 -2 does not contain the C2 domain. In all cDNA clones analyzed, we consistently found a stop codon upstream of the initiating methionine, which fits well the consensus sequence for translation initiation (38) . This stop codon is present in all mouse EST sequences covering this region, making it unlikely that there is a sequencing or cloning artifact. In support of this, expression of mNedd4 -2 lacking the C2 domain in Xenopus oocytes yields a protein of similar size to the one detected by several anti-Nedd4 antibodies in mpkCCD c14 (Fig. 3A) . When a mpkCCD c14 cell lysate is separated on 2D gels, a protein migrates at the predicted molecular weight and pI and is recognized by the anti Nedd4 antibodies (Fig. 3B) . Hence, mNedd4 -2 expressed in mpkCCD c14 does not contain a C2 domain at its NH 2 terminus. Moreover, our data show that mNedd4 -2 is fully functional in regulating rENaC when coexpressed in Xenopus oocytes, indicating that, at least in these cells, the C2 domain is not required for rENaC control. The lack of a C2 domain suggests that localization of mNedd4 -2 is not regulated by intracellular calcium levels as has been shown for Nedd4 -1 in MDCK cells (42) and that regulation of rENaC by intracellular calcium (43) does involve factors other than mNedd4 -2. It is noteworthy that the presence of a C2 domain is also uncertain in hNedd4 -2, as the first methionine in this sequence corresponds to the one in mNedd4 -2; however, the sequence in GenBank may only be partial.
We demonstrate for the first time functional and biochemical specificity among close members of the Nedd4 family of ubiquitin-protein ligases: the observation that only mNedd4 -2, but not Nedd4 -1 (from either mouse, rat, or human; data not shown), binds and regulates rENaC illustrates that the presence of WW domains is not sufficient for a protein to interact with any given PY motif-containing proteins. Other factors, such as the nature of the WW domains or of the PY motif, sterical hindrance, or cofactors like E2 enzymes, may play a role. Our results also demonstrate the importance of in vivo data as compared with in vitro binding analysis. We and others have shown by various approaches, including the two-hybrid system, binding/ competition assays, and coimmunoprecipitation from cells overexpressing ␣ rENaC, that the individual WW domains of Nedd4 -1 can bind to the PY motifs of rENaC (18, 25, 41, 44) . These results must now be reevaluated. It is important to determine, for example, whether there is a difference in the binding affinities to rENaC between the WW domains of Nedd4 -1 and Nedd4 -2. Moreover, it will be necessary to develop ϩ currents (I Na ) from oocytes injected with cRNA encoding rENaC and either wild-type xNedd4 or xNedd4 containing mutations in the individual WW domains (WW domains 1-4). n ϭ 17 oocytes from 3 frogs; *PϽ0.05, **PϽ0.01 vs. wild-type xNedd4. N.S., not significant. B) Dose-response relationship of the effect of xNedd4 containing either mutated WW domains 1 and 2 or mutated WW domains 3 and 4 on rENaC activity. Top: Immunoblot analysis showing expression of xNedd4 with increasing amounts of xNedd4 cRNA. Bottom: Corresponding normalized I Na . The measured oocytes were normalized to control oocytes (i.e., 0 ng of xNedd4 cRNA). *PϽ0.05, **PϽ0.01 vs. control oocytes. nϭ15 oocytes from 3 frogs.
methods that determine the affinity between Nedd4 isoforms and the entire assembled rENaC complex.
It also follows that the two isoforms, which are expressed within the same cells (mpkCCD c14 ), are not functionally redundant and that the physiological substrate(s) for Nedd4 -1 remains to be identified. This is further supported by the observation that the two isoforms exhibit different patterns of expression. Whereas mNedd4 -1 is expressed in all tissues analyzed (Fig. 2, middle panel) , mNedd4 -2 mRNA is more restricted, with highest expression in the liver and kidney and less abundant in the other tissues examined. The observation that mNedd4 -2 expression in the lung is very weak correlates well with the fact that no lung phenotype is observed in Liddle's patients.
Our results showing that Nedd4 -1 does not regulate rENaC activity contrast with the data published by Goulet et al. (24) , who reported that rNedd4 suppresses human ENaC activity by ϳ80% when coexpressed in Xenopus oocytes and that the catalytically inactive rNedd4 mutant (rNedd4-C854S) does not influence rENaC activity. We cannot explain this discrepancy, as Goulet et al. (24) provide very little information on the forms of Nedd4 they used. Nevertheless, one would expect that an enzymatically inactive mutant protein, which preserves the binding sites for its substrate, would enter into competition with endogenous xNedd4 (present in the oocyte) (23) and should therefore increase rENaC activity.
The data in this paper provide fascinating insights into the mechanism on how Nedd4 -2 binds to and regulates rENaC. An interesting point is revealed by the finding that the same amounts of rENaC are immunoprecipitated from oocytes coinjected with rENaC and either wild-type or mutant Nedd4 -2 (Fig. 5B) . This is remarkable since expression of Nedd4 -2 leads to the complete inhibition of rENaC activity, which is likely due to the loss of rENaC channels at the cell surface (23) . Two explanations are plausible: either the amount of cell surface rENaC, which becomes ubiquitinated and degraded, is negligible compared to the total cellular pool or rENaC is recycled after internalization and deubiquitination. The finding that comparable amounts of wild-type or mutant Nedd4 coimmunoprecipitate with rENaC suggests that Nedd4 -2 binds to intracellular ENaC channels and that this binding does not lead to the immediate ubiquitination/ degradation of the rENaC complex. We speculate that inactive mNedd4 -2 may be bound to intracellular rENaC and would be activated by some unknown mechanism on translocation to the plasma membrane. Such activation will then lead to ubiquitination of rENaC, dissociation of mNedd4 -2, and internalization of the channel complex.
The experiments done with either an amino-terminally truncated form of mNedd4 -2 (Fig. 4) or xNedd4-containing mutations in the individual WW domains (Fig. 7) suggest that mainly the third and fourth WW domains, but not the first and second, are involved in rENaC binding. On the other hand, the three PY motifs (or even four, if one considers the channel stoichiometry of 2␣1␤1␥; ref 45 ) seem to play a role for Nedd4 binding. It appears that the ␤ PY motif is functionally different from those on ␣ or ␥ rENaC, as it causes a lower I Na when present alone as compared to the other PY motifs (compare columns 5-7, or 13-15, or 21-23) or a higher current when mutated alone (compare columns 2-4, or 10 -12, or 18 -20) . These effects seem to be independent of mNedd4 -2 and may be due to changed open probability as has been demonstrated for Liddle's channels (33) . Taken together, our data suggest that there are several functionally relevant binding modes for the interaction with Nedd4, which also include the PY motif of ␣rENaC, but the nature of these interactions remain to be determined experimentally.
Our finding that all three PY motifs are involved in interaction with Nedd4 have important implications for understanding Liddle's syndrome. To date, all of the identified mutations causing Liddle's syndrome either delete or mutate one PY motif on ␤ or ␥ENaC, thereby destroying one binding site for Nedd4. To our knowledge, no mutations on ␣ENaC or Nedd4 that would cause Liddle's syndrome have been reported, although we predict that such mutations exist. In the case of Nedd4 -2, this may be simply because it is an essential protein (as is the case in yeast; see ref 46) , and hence null mutations may be lethal. It is possible, however, that investigations have focused so far on the wrong genetic locus (encoding the classical hNedd4 -1), that localized on chromosome 15. Searching for mutations in the gene encoding for hNedd4 -2, situated on chromosome 18, will likely be more promising.
In summary, we have shown that a novel mouse Nedd4 isoform (mNedd4 -2), and not the originally identified mNedd4 -1, does regulate rENaC when coexpressed in Xenopus oocytes and that the lack of regulatory competence of mNedd4 -1 is mainly due to its inability to bind to the rENaC complex. Moreover, we showed that all the PY motifs on the rENaC complex and WW domains 3 and 4 on mNedd4 -2 are involved in the interaction. Hence, our data suggest that Nedd4 -2 is a novel suppressor protein of rENaC and therefore a susceptibility gene for arterial hypertension.
